WH Bakker - Concepedia

Author

WH Bakker

Rotterdam University of Applied Sciences

Also Known As

W H Bakker, W. H. Bakker, W.H. Bakker, WH Bakker

Publications

962

Citations

H-Index

Concepts

All Affiliations

Rotterdam University of Applied Sciences

About

WH Bakker is an author at Rotterdam University of Applied Sciences specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	815
2	Engineering	4	4	760
3	Health Sciences	1	1	10
4	Endocrinology	1	1	422
5	Molecular Biology	1	1	10

WH Bakker

Publications

922

Citations

H-Index

Page 1

	Year	Citations
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. E. P. Krenning, WH Bakker, P P Kooij, PubMed EngineeringPathologyPositron Emission TomographyTheranosticsNormal Pituitary	1992	422
Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. M. de Jong, W A Breeman, WH Bakker, PubMed EngineeringChemoprevention StrategyIn-labeled SomatostatinTumor BiologyMedicinal Chemistry	1998	210
Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide. E. P. Krenning, Roelf Valkema, P.P.M. Kooij, PubMed EngineeringPositron Emission TomographyTheranosticsRadiopharmaceutical TherapyMolecular Imaging	1999	118
Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptake. D J Kwekkeboom, P.P.M. Kooij, WH Bakker, PubMed	1999	107
Phase I study of therapy with Y-90-SMT487 (octreother) in patients with somatostatin receptor (SS-R) positive tumors. Roelf Valkema, François Jamar, Stanislas Pauwels, DIAL (Catholic University of Leuven) Positive TumorsEndocrine OncologyOncologyMedicinePathology	2002	18
Octreotide scintigraphy localizes somatostatin receptor-positive islet cell carcinomas W. Becker, Jörg Marienhagen, Robert Scheubel, European Journal of Nuclear Medicine and Molecular Imaging Somatic VariantMedicineOctreotide ScintigraphyPathologyMolecular Diagnostics	1991	15
Safety and efficacy of [Y-90-DOTA,Tyr(3)]-octreotide (Y-90-SMT487; OctreoTher) peptide receptor radionuclide therapy (PRRT). Preliminary results of a phase-1 study Roelf Valkema, François Jamar, Stanislas Pauwels, DIAL (Catholic University of Leuven) Phase-1 StudyMedicineRadionuclide TherapyPreliminary ResultsRadiopharmaceutical Therapy	2001	12
Evaluation of a radiolabeled cyclic DTPA-RGD analog for tumor imaging and radionuclide therapy Marion de Jong, Martin van Hagen, Wout A. P. Breeman, Nuclear Medicine Communications Oncologic ImagingImaging AgentPeptide ScienceTumor ImagingOncology	2000	10
Somatostatin receptor imaging with 123I-Tyr3-octreotide S. W. J. Lamberts, J.C. Reubi, WH Bakker, European Journal of Cancer and Clinical Oncology Molecular PhysiologySignal TransductionEngineeringReceptor (Biochemistry)Molecular Biology	1990	10

Page 1